Erik Harris
EVP & Chief Commercial Officer · 2 filings · Latest: Apr 16, 2026
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RARE | Erik Harris | EVP & Chief Commercial Officer | Mar 2, 2026 | Sale | $22.80 | 10,539 | $240.3K | 89,515 |